METHOD FOR OPTIC NERVE ATROPHY TREATMENT AFTER CRANIOCEREBRAL INJURY Russian patent published in 2017 - IPC A61N1/30 A61K31/7068 A61K33/14 A61K38/48 A61P27/00 A61M5/178 

FIELD: medicine.

SUBSTANCE: when treating optic nerve atrophy after a craniocerebral injury, 1000 mg of Recognan in 4 ml of 0.9% saline is injected intravenously once a day. In addition, from the first day of treatment, 10 sessions of endonasal electrophoresis are performed from the negative pole for 20 min with 10 mg of chymotrypsin, diluted in 5 ml of 0.2% saline. The course of treatment is 10 days.

EFFECT: method provides stabilization of visual functions while reducing the pharmacological load on the body, long term effect, absence of complications associated with the central nervous system.

2 ex